Objetivo do estudo: To evaluate the maximum tolerated dose (MTD) of choline salicylate (CS) that can be combined with selinexor twice weekly in patients with relapsed/refractory diffuse large B cell lymphoma (DLBCL) or mantle cell lymphoma (MCL). (Primary)

Pesquisador principal:  Jonas Paludo, M.D., Mayo Clinic in Rochester, Minnesota, United States

Informações de contato: Clinical Trials Referral Office   Phone: +1-855-776-0015   Email: mayocliniccancerstudies@mayo.edu  

Envolvimento solicitado do paciente: 18 Years and older 

Identificador do ClinicalTrials.gov: NCT04640779